Support PenkeSilverback Therapeutics Inc - Trending symbols
Latest News of Silverback Therapeutics Inc
| Date | Title | Read |
|---|---|---|
| 2025-05-06 19:35 | ARS Pharmaceuticals And 2 Other Growth Leaders With Insider Ownership | Read |
| 2025-05-02 14:00 | ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians | Read |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income before Tax | -7,168 | -3,124 | -10,292 | -2,224 | -12,516 | -6,612 | -19,128 | 69,350 | 50,222 | |
| Net Income | -7,168 | -3,124 | -10,292 | -2,224 | -12,516 | -6,612 | -19,128 | 69,062 | 49,934 | |
| EBITDA | -10,214 | -2,967 | -13,181 | -2,141 | -15,322 | -6,426 | -21,748 | 68,945 | 47,197 | |
| Operating Income | -10,226 | -2,966 | -13,192 | -2,148 | -15,340 | -6,408 | -21,748 | 68,945 | 47,197 | |
| Net Income from Continuing Operations | -7,168 | -3,124 | -10,292 | -2,224 | -12,516 | -6,612 | -19,128 | 69,062 | 49,934 | |
| Gross Profit | -7,298 | 7,277 | -21 | -21 | -42 | 31 | -11 | 493 | 482 | |
| Reconciled Depreciation | 299 | -279 | 20 | 0 | 20 | 1 | 21 | -6,887 | -6,866 |
Comments
How you think about this?